rs753151750
Variant summary
Our verdict is Uncertain significance. The variant received -1 ACMG points: 0P and 1B. BP4
This summary comes from the ClinGen Evidence Repository: The c.3584C>T (NM_006939.4(SOS2):c.3584C>T (p.Ala1195Val)) variant in SOS2 is a missense variant predicted to cause substitution of alanine by valine at amino acid 1195. The filtering allele frequency in gnomAD v2.1.1 is 0.003446 % (no population codes met). The computational predictor REVEL gives a score of 0.183 which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7176746/MONDO:0021060/042
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SOS2 | ENST00000216373.10 | c.3584C>T | p.Ala1195Val | missense_variant | Exon 23 of 23 | 1 | NM_006939.4 | ENSP00000216373.5 | ||
| SOS2 | ENST00000543680.5 | c.3485C>T | p.Ala1162Val | missense_variant | Exon 22 of 22 | 1 | ENSP00000445328.1 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151394Hom.: 0 Cov.: 30 show subpopulations
GnomAD2 exomes AF: 0.0000360 AC: 9AN: 249676 AF XY: 0.0000370 show subpopulations
GnomAD4 exome AF: 0.0000349 AC: 51AN: 1460916Hom.: 0 Cov.: 33 AF XY: 0.0000358 AC XY: 26AN XY: 726744 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151510Hom.: 0 Cov.: 30 AF XY: 0.0000541 AC XY: 4AN XY: 73974 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
SOS2: BP4 -
Cardiovascular phenotype Uncertain:1
The p.A1195V variant (also known as c.3584C>T), located in coding exon 23 of the SOS2 gene, results from a C to T substitution at nucleotide position 3584. The alanine at codon 1195 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
RASopathy Uncertain:1
The c.3584C>T (NM_006939.4(SOS2):c.3584C>T (p.Ala1195Val)) variant in SOS2 is a missense variant predicted to cause substitution of alanine by valine at amino acid 1195. The filtering allele frequency in gnomAD v2.1.1 is 0.003446 % (no population codes met). The computational predictor REVEL gives a score of 0.183 which is below the threshold of 0.3, evidence that does not predict a damaging effect on SOS2 function (BP4). In summary, this variant meets the criteria to be classified as uncertain significance for autosomal dominant RASopathy, based on the ACMG/AMP criteria applied, as specified by the ClinGen RASopathy VCEP: BP4 (Version 2.3; 12/3/2024). -
Noonan syndrome 9 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at